State Street’s Maravai LifeSciences MRVI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.87M Buy
2,428,717
+14,468
+0.6% +$49.1K ﹤0.01% 2803
2025
Q4
$7.85M Buy
2,414,249
+27,219
+1% +$91.6K ﹤0.01% 2770
2025
Q3
$6.85M Buy
2,387,030
+5,719
+0.2% +$14.6K ﹤0.01% 2848
2025
Q2
$5.74M Sell
2,381,311
-345,443
-13% -$726K ﹤0.01% 2885
2025
Q1
$6.03M Sell
2,726,754
-54,043
-2% -$214K ﹤0.01% 2805
2024
Q4
$15.2M Buy
2,780,797
+30,024
+1% +$193K ﹤0.01% 2377
2024
Q3
$22.9M Sell
2,750,773
-16,338
-0.6% -$141K ﹤0.01% 2129
2024
Q2
$19.8M Buy
2,767,111
+730,837
+36% +$6.31M ﹤0.01% 2177
2024
Q1
$17.7M Buy
2,036,274
+20,906
+1% +$141K ﹤0.01% 2248
2023
Q4
$13.2M Buy
2,015,368
+207,869
+12% +$1.34M ﹤0.01% 2437
2023
Q3
$18.1M Sell
1,807,499
-26,994
-1% -$296K ﹤0.01% 2227
2023
Q2
$22.8M Sell
1,834,493
-5,975
-0.3% -$80.6K ﹤0.01% 2168
2023
Q1
$25.8M Buy
1,840,468
+32,279
+2% +$464K ﹤0.01% 2052
2022
Q4
$25.9M Buy
1,808,189
+53,213
+3% +$838K ﹤0.01% 2050
2022
Q3
$44.8M Buy
1,754,976
+6,088
+0.3% +$153K ﹤0.01% 1663
2022
Q2
$49.7M Sell
1,748,888
-61,429
-3% -$1.95M ﹤0.01% 1638
2022
Q1
$63.9M Buy
1,810,317
+201,284
+13% +$6.75M ﹤0.01% 1604
2021
Q4
$67.4M Buy
1,609,033
+222,158
+16% +$9M ﹤0.01% 1599
2021
Q3
$68.1M Buy
1,386,875
+166,491
+14% +$8.12M ﹤0.01% 1578
2021
Q2
$50.9M Buy
1,220,384
+571,855
+88% +$22.2M ﹤0.01% 1834
2021
Q1
$23.1M Buy
+648,529
New +$21.5M ﹤0.01% 2277

Other funds holding MRVI